home / stock / crmd / crmd news

CRMD News and Press, CorMedix Inc. From 11/10/22

Stock Information
Company Name: CorMedix Inc.
Stock Symbol: CRMD
Market: NYSE
Website: cormedix.com
Menu
CRMD CRMD Quote CRMD Short CRMD News CRMD Articles CRMD Message Board
Get CRMD Alerts

News, Short Squeeze, Breakout and More Instantly...
CRMD - CorMedix Inc. Reports Third Quarter 2022 Financial Results and Provides Business Update

BERKELEY HEIGHTS, N.J., Nov. 10, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases, today announced financial results ...
CRMD - CorMedix Inc. Announces CMS Revision to NTAP Reimbursement of DefenCath

BERKELEY HEIGHTS, N.J., Nov. 07, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases, today announced that the Cente...

CRMD - CorMedix Inc. to Report Third Quarter 2022 Financial Results and Provide a Corporate Update on November 10

BERKELEY HEIGHTS, N.J. , Nov. 02, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases, today announced that it w...

CRMD - CorMedix Inc. Announces Abstract Presentation at Upcoming American Society of Nephrology Conference

BERKELEY HEIGHTS, N.J., Oct. 20, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases, today announced that an abstract h...
CRMD - CorMedix Inc. to Present at the H.C. Wainwright Annual Global Investment Conference

BERKELEY HEIGHTS, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that management will b...

CRMD - CorMedix Inc. (CRMD) CEO Joseph Todisco on Q2 2022 Results - Earnings Call Transcript

CorMedix Inc. (CRMD) Q2 2022 Earnings Conference Call August 11, 2022 08:30 ET Company Participants Daniel Ferry - LifeSci Advisors, LLC Erin Mistry - Senior Vice President and Head, Payer Strategy, Government Affairs and Trade Joseph Todisco - Chief Executive Of...

CRMD - CorMedix Inc Common Stock (CRMD) Q2 2022 Earnings Call Transcript

Image source: The Motley Fool. CorMedix Inc Common Stock (NASDAQ: CRMD) Q2 2022 Earnings Call Aug 11, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: CorMedix Inc Common Stock (CRMD) Q2 2022 Earnings Call Transcript...
CRMD - CorMedix GAAP EPS of -$0.19 beats by $0.02, revenue of $0.02M

CorMedix press release ( NASDAQ: CRMD ): Q2 GAAP EPS of -$0.19 beats by $0.02 . Revenue of $0.02M (+100.0% Y/Y). Joe Todisco, CorMedix CEO, commented, “While I am disappointed that we will not receive FDA approval on our PDUFA date, I remain confident in our...

CRMD - CorMedix Inc. Reports Second Quarter and Six Month 2022 Financial Results and Provides Business Update

BERKELEY HEIGHTS, N.J., Aug. 11, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced financial results for t...

CRMD - Notable earnings before Thursday's open

Major earnings expected before the bell on Thursday include: Arrival ( ARVL ) Brookfield Asset Management ( BAM ) Cardinal Health ( CAH ) Hanesbrands ( HBI ) Himax Technologies ( HIMX ) For further details see: Notable earnings before Thur...
Previous 10 Next 10